Safety and Efficacy Study of KAI-1678 to Treat Pain in Subjects With Postherpetic Neuralgia

Clinical trial NCT01106716 · COMPLETED

Trial details

NCT number: NCT01106716
Sponsor: KAI Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Postherpetic Neuralgia

Start date: 2009-03-01
Primary completion: 2010-03-01
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.